Search Within

Govindaswami Ragupathi

Formats
  1. Journal Article (90)
  2. Meeting Abstract (50)
  3. Book Section (5)
Groups
  1. Department of Medicine (145)
  2. Melanoma Disease Management Team (145)
  3. Melanoma and Immunotherapeutics Service (145)
  4. Solid Tumor Oncology Division (145)
  5. Sloan Kettering Institute Faculty (57)
  6. Molecular Pharmacology and Chemistry Program Faculty (52)

More Groups

People
  1. Philip Livingston (118)
  2. Samuel Danishefsky (44)
  3. Kenneth Lloyd (17)
  4. Maria Spassova (17)
  5. Howard Scher (16)
  6. Susan Slovin (15)

More People

Years
  1. 2025 (1)
  2. 2023 (3)
  3. 2022 (2)
  4. 2021 (2)
  5. 2020 (1)
  6. 2019 (2)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (24)
  2. Cancer Research (20)
  3. Cancer Immunology, Immunotherapy (15)
  4. Clinical Cancer Research (13)
  5. Journal of the American Chemical Society (8)
  6. Vaccine (7)

More Publications

Publishers
  1. American Association for Cancer Research (57)
  2. Springer (20)
  3. American Chemical Society (14)
  4. Elsevier Inc. (9)
  5. John Wiley & Sons (4)
  6. National Academy of Sciences (4)

More Publishers

Results (145)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • GD2 antibodies prevent tumor recurrence after foot-pad challenge followed by amputation despite impact of micrometastases
    Meeting Abstract

    Koide, F.; Gathuru, J.; Kim, S. K.; Ragupathi, G.; Cheung, N. K.; Livingston, P. O.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Synthesis of selected LeY and KH-1 analogues: A medicinal chemistry approach to vaccine optimization
    Journal Article

    Spassova, M. K.; Bornmann, W. G.; Ragupathi, G.; Sukenick, G.; Livingston, P. O.; Danishefsky, S. J.
    Journal of Organic Chemistry (2005)

    Fulltext@MSK | Save
  • Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: Clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer
    Journal Article

    Slovin, S. F.; Ragupathi, G.; Musselli, C.; Fernandez, C.; Diani, M.; Verbel, D.; Danishefsky, S.; Livingston, P.; Scher, H. I.
    Cancer Immunology, Immunotherapy (2005)

    Fulltext@MSK | Save
  • A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: A study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 or QS-21
    Journal Article

    Slovin, S. F.; Ragupathi, G.; Fernandez, C.; Jefferson, M. P.; Diani, M.; Wilton, A. S.; Powell, S.; Spassova, M.; Reis, C.; Clausen, H.; more...
    Vaccine (2005)

    Fulltext@MSK | Save
  • Carbohydrate vaccines as immunotherapy for cancer
    Journal Article

    Slovin, S. F.; Keding, S. J.; Ragupathi, G.
    Immunology and Cell Biology (2005)

    Fulltext@MSK | Save
  • Antibodies against tumor cell glycolipids and proteins, but not mucins, mediate complement-dependent cytotoxicity
    Journal Article

    Ragupathi, G.; Liu, N. X.; Musselli, C.; Powell, S.; Lloyd, K.; Livingston, P. O.
    Journal of Immunology (2005)

    Fulltext@MSK | Save
  • Antibody inducing polyvalent cancer vaccines
    Journal Article

    Ragupathi, G.; Gathuru, J.; Livingston, P.
    Cancer Treatment and Research (2005)

    Fulltext@MSK | Save
  • Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy
    Journal Article

    Livingston, P. O.; Hood, C.; Krug, L. M.; Warren, N.; Kris, M. G.; Brezicka, T.; Ragupathi, G.
    Cancer Immunology, Immunotherapy (2005)

    Fulltext@MSK | Save
  • Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn
    Journal Article

    Kagan, E.; Ragupathi, G.; Yi, S. S.; Reis, C. A.; Gildersleeve, J.; Kahne, D.; Clausen, H.; Danishefsky, S. J.; Livingston, P. O.
    Cancer Immunology, Immunotherapy (2005)

    Fulltext@MSK | Save
  • Identification of DHBcAg as a potent carrier protein comparable to KLH for augmenting MUC1 antigenicity
    Journal Article

    Gathuru, J. K.; Koide, F.; Ragupathi, G.; Adams, J. L.; Kerns, R. T.; Coleman, T. P.; Livingston, P. O.
    Vaccine (2005)

    Fulltext@MSK | Save